The CenterWatch Weekly, May 31, 2016
Blockchain technology holds promise as trial data authentication tool
Blockchain technology has the potential to maintain the integrity of clinical trial reports and essentially automate trust in the reliability of research findings, according to a recent proof-of-concept study by researchers with the University of Cambridge, U.K. First used in software development, blockchain is a digital storage system that allows blocks of data, including documents, to be permanently encoded and timestamped. Once a document is added to a blockchain database, third parties can verify its existence and exact wording at a particular point in time. The original document can’t be altered, but revised versions can be encoded, timestamped and added to the chain.
ClinTec International expanding in Spain to capitalize on improving Spanish market
With an improving Spanish pharmaceutical market, ClinTec International has identified the country as a target market for expansion. Following a year of steady growth by ClinTec’s Spain-based team, the global CRO is capitalizing on the improving Spanish economy by opening two new offices, and creating a new regional manager position, which will oversee both Spanish and Portuguese markets. The expansion includes a move to larger Barcelona offices, the opening of a new office in Madrid and the creation of regional manager position.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.